Pneumonia Outcomes Worse for Diabetics

FEBRUARY 01, 2006

Researchers in Spain, who noted that diabetes is common in patients with pneumonia, examined whether the clinical features and outcomes of pneumonia were altered by the presence of diabetes. The results of their study showed that patients with diabetes had more serious pneumonia and more hospital stays, compared with patients without diabetes.

The researchers further reported that diabetes was independently associated with a higher risk of death from pneumonia. The patients with diabetes who died of pneumonia had more underlying diseases and diabetes-related problems. The microorganisms responsible for the pneumonia, however, were the same in both the patients with diabetes and the control group, according to the report in Chest (November 2005).




SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.